Leaflet BERIRAB P solution for intramuscular injection

Product code:
W13474001
Quantity:
1
Indicated for:
immunosuppression
Route of administration:
intramuscular
Substance:
specific rabies immunoglobulin (immunoglobulin)
ATC
J06BB05 — Antiinfectives for systemic use | Immunoglobulins | Specific immunoglobulins

Precautions:

Anaphylaxis

Anaphylaxis

Risk of severe allergic reaction. Seek urgent medical help if serious symptoms occur.

Additional monitoring

Additional monitoring

This medicine is subject to additional monitoring.

Specific anti-rabies immunoglobulin is used for the prevention of rabies in patients exposed to the rabies virus, such as through bites from suspected animals. It provides passive protection by neutralizing the virus before the body develops an immune response.

The medication is administered intramuscularly, as directed by a doctor, usually in combination with the rabies vaccine. It is important to administer it as soon as possible after exposure.

Side effects may include pain at the injection site, fever, or allergic reactions. In rare cases, anaphylactic reactions may occur.

Specific anti-rabies immunoglobulin is not recommended for patients with hypersensitivity to human immunoglobulins or severe IgA deficiency.

General data about BERIRAB P

Substance:
specific rabies immunoglobulin
Date of latest medicines list:
01-07-2013
Product code:
W13474001
Pharmaceutical form:
solution for intramuscular injection
Quantity:
1
Product type:
Generic medicine
Prescription status:
S — Medicines dispensed with a restricted medical prescription, reserved for use in certain specialized fields.